Ebola Hemorrhagic Fever, www.CDC.gov

Looming Pressure on Pharma as the Spread of Ebola Continues

When will a vaccine become available for Ebola? Killing over 8,000 people in West Africa since last year and still spreading, the need for a prophylactic Ebola vaccine is becoming increasingly important. Companies are racing to bring a safe vaccine to market and with the current pace of the epidemic in Liberia, Sierra Leone and Guinea, the demand for Ebola …

Chikungunya Vaccine Succeeds in Phase I: Paving the way for a new generation of vaccines

Themis Bioscience and the Institut Pasteur announce positive chikungunya vaccine results in phase I using revolutionary measles vector Vienna-based Themis Bioscience, and the Paris based Institut Pasteur announced earlier this week a successful phase I trial of their revolutionary chikungunya vaccine. The phase 1 trial of 42 subjects demonstrated the vaccine to be well tolerated and safe. The trial also …

Themis Bioscience’s Vaccine against Chikungunya Successful in Phase 1

Results presented at international conferences in Philadelphia and New Orleans November 20, 2014 The induction of neutralizing antibodies by a prophylactic Chikungunya vaccine candidate has now been confirmed by the final results of a phase 1 clinical trial, as well as its tolerability and safety. Detailed information of the trial has been presented at two international conferences. The vaccine candidate …

Chikungunya vaccine candidate causes successful development of antibodies against the virus

Chikungunya Vaccine Candidate Passes Phase I Clinical Trials

Chikungunya vaccine candidate causes successful development of antibodies against the virus Chikungunya, a mosquito borne virus, has recently been responsible for outbreaks in the Caribbean and the Pacific. Although the disease is not usually fatal, it causes similar symptoms to a bad flu: muscle aches, malaise and headaches. However, one of the unique aspects of the virus is that it …

VGTI Florida Aims to Stop Spread of Chikungunya Virus with Novel Vaccine

No licensed vaccine exists for mosquito-borne threat that has reached U.S. Virus-like particle platform technology could also target Ebola virus Scheduled to exhibit at Military Health System Research Symposium August 11, 2014 It’s another soaking wet rainy season in South Florida, and with it comes ideal conditions for mosquitos to breed and thrive, but this summer brings fears beyond just …

Integral Molecular Announces Patent Allowance for Dengue Research Technology

July 17, 2014 Integral Molecular, a leader in membrane protein research, announces the issuance of a new composition patent protecting dengue reporter virus particles (RVPs). The invention relates to the company’s chimeric and codon-optimized flavivirus replicons, expression plasmids, and RVPs used for infectivity, neutralization, enhancement and structure-function studies of dengue virus (DENV) and its envelope protein (prM/E). U.S. Patent No …

10 of the Most Important Diseases With No Licensed Vaccine

Vaccination has been successful at controlling many of the world’s diseases. However, there still remain many infectious diseases for which no licensed (US or EU) vaccine exists. Here I’ve selected 10 of them – arranged in no particular order – which I think are especially important. Click Next to read them > I look forward to hearing your thoughts. Next …